Related Experiment Video
Updated: Jun 16, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Clostridioides difficile Infections in Children: What Is the Optimal Laboratory Diagnostic Method?
Mohammed Suleiman1, Patrick Tang1,2, Omar Imam3
1Department of Pathology, Sidra Medicine, Doha P.O. Box 26999, Qatar.
Insights
Diagnosing Clostridioides difficile infection (CDI) in children is challenging. An algorithm using PCR or a gastrointestinal panel followed by toxin immunoassay offers the best performance for pediatric CDI diagnosis.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Microbiology
- Diagnostic Test Evaluation
Background:
- Clostridioides difficile infection (CDI) diagnosis in children is complex due to high asymptomatic colonization rates.
- Optimal laboratory diagnostic strategies for pediatric CDI remain debated.
- Evaluating commercial diagnostic tests is crucial for accurate pediatric CDI detection.
Purpose of the Study:
- To compare the performance of various commercial diagnostic tests and algorithms for Clostridioides difficile infection (CDI) in a pediatric population.
- To identify the most effective testing strategy for diagnosing CDI in children aged 0-18 years.
- To assess diagnostic performance based on turnaround time, cost, and clinical utility.
Main Methods:
- 374 pediatric stool samples (June-December 2023) were tested using Techlab C. diff Quik Chek Complete, Cepheid GeneXpert C. difficile, QIAstat-Dx Gastrointestinal Panel, and CHROMagar C. difficile culture.
- Standalone tests and four distinct testing algorithms were evaluated against a composite reference standard.
- Performance metrics included sensitivity, specificity, positive predictive value, and negative predictive value.
Main Results:
- Significant variability in performance was observed among the different diagnostic assays for pediatric CDI.
- An algorithm combining Cepheid GeneXpert PCR or QIAstat-Dx panel as initial screening, followed by Techlab C. diff Quik Chek Complete toxin immunoassay for positive results, demonstrated optimal performance.
- This optimized algorithm achieved 100% specificity and 100% positive predictive value when integrated with clinical assessment.
Conclusions:
- The choice of diagnostic method significantly impacts Clostridioides difficile infection (CDI) diagnosis accuracy in children.
- A multi-step algorithm incorporating molecular screening and toxin detection, alongside clinical evaluation, is recommended for pediatric CDI diagnosis.
- This approach enhances diagnostic confidence and optimizes resource utilization in pediatric settings.
Abstract:
The diagnosis of Clostridioides difficile infection (CDI) in the pediatric population is complicated by the high prevalence of asymptomatic colonization, particularly in infants. Many laboratory diagnostic methods are available, but there continues to be controversy over the optimal laboratory testing approach to diagnose CDI in children. We evaluated commonly used C. difficile diagnostic commercial tests in our pediatric hospital population at Sidra Medicine in Doha, Qatar. Between June and December 2023, 374 consecutive stool samples from pediatric patients aged 0-18 years old were tested using: Techlab C. diff Quik Chek Complete, Cepheid GeneXpert C. difficile, QIAstat-Dx Gastrointestinal Panel, and culture using CHROMagar C. difficile. The results of these tests as standalone methods or in four different testing algorithms were compared to a composite reference method on the basis of turnaround time, ease of use, cost, and performance characteristics including specificity, sensitivity, negative predictive value, and positive predictive value. Our study showed variability in test performance of the different available assays in diagnosing CDI. In our population, a testing algorithm starting with Cepheid GeneXpert C. difficile PCR assay or QIAstat-Dx Gastrointestinal panel as a screening test followed by toxin immunoassay for positive samples using the Techlab C. diff Quik Chek Complete kit showed the best performance (100% specificity and 100% positive predictive value) when combined with clinical review of the patient to assess risk factors for CDI, clinical presentation, and alternative causes of diarrhea.
Related Concept Videos
Rapid Identification of Pathogens
Automated Microbial Diagnostics

